To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
The François Jacob Institute of Biology brings together five departments and three services
The last two years in scientific news
Researchers from the IDMIT department have developed an antibody capable of simultaneously blocking two immune brakes to strengthen the antiviral response against HIV.
Genoscope researchers identify, among the many microorganisms colonizing plastics in marine environments, those that are genuinely involved in their degradation.
DRCM researchers have identified a new mechanism regulating separase, a key enzyme involved in sister chromatid separation.
Genoscope researchers describe a complete pathway enabling DMS to be used as a sulfur source.
From the first cultured epidermal grafts used to treat severely burned patients to today’s cell therapy, gene therapy and 3D bioprinting approaches, skin substitutes have emerged as one of the pioneering fields of regenerative medicine.
SRHI researchers have identified a new population of effector immune cells that could potentially be harnessed to develop complementary immunotherapy approaches for the treatment of kidney cancer.
On July 19, 2026, Genoscope set off from the port of Lorient aboard the Tara Polaris I expedition, the first in a series of ten scientific expeditions planned over the next 20 years.
The Institute’s IDMIT Department has successfully renewed the certification of its quality management system in accordance with the ISO 9001:2015 standard. Valid until July 2029, the certification covers all of its research activities and preclinical services in the fields of infectious diseases and immune system disorders.
Tom Delmont, a researcher at the Genoscope Metabolic Genomics Laboratory, has been awarded the 2026 CNRS Bronze Medal.
Institut Jacob and Institut Joliot published a stufu providing policymakers with a structured tool to analyse critical dependencies, guide investments, and strengthen Europe's strategic autonomy in the biomedical field.
Among Inserm’s 350 research units, the work carried out by IDMIT Department on the characterization of a vaccine against the monkeypox virus is among the 36 scientific advances selected by Inserm for 2025.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.